The current findings provide a theoretical and experimental basis, but the mechanisms of the hsa-miR-933/RELB/CCL21 regulatory axis in the development of HF and neurological disorders should be validated by cellular and animal experiments. The gene discussed is CCL21; the disease is nervous system disorder.